Cuba teams with China's Lukang to manufacture biotech products; Catalent, BASF take on solubility challenges;

> Cuba's Center for Genetic Engineering and Biotechnology and Lukang Pharmaceutical in China announced plans to cooperatively manufacture and market biotechnology products. Item

> Catalent and BASF will jointly market technology to address drug solubility issues to help companies formulate optimal dose form from development through scale-up and supply. Story

> Nepal's Department of Drug Administration is writing good manufacturing practice (GMP) regulations that will meet World Health Organization (WHO) standards in expectation of raising drug manufacturing standards and making the country's pharmaceuticals more acceptable internationally. Article

> US Pharmacopeia (USP) is investing $1.5 million and looking for donors to set up a facility which will fund itself offering quality control services to pharmaceutical manufacturers in Sub-Saharan Africa. Story

> Omkar Specialty Chemicals in India has acquired LASA Laboratory, which has an API manufacturing facility that makes mostly active ingredients for veterinary pharmaceuticals. More

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.